Eton Pharmaceuticals, Inc. (ETON)
Pharmaceutical Preparations
Latest Price
$57.62
TTM P/E
147.74
Normalized P/E
2.90
Div Yield
--
Book Value
1.70
P/B Ratio
33.94
Valuation metrics
adjust assumptions →Base FCF: $6M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$16.11
72% downside
Institutional Ownership
70.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2.86M | $103.0M | 10.11% | -- | 2026-06-30 |
| EcoR1 Capital, LLC | 2.17M | $78.0M | 7.68% | -- | 2026-06-30 |
| BlackRock, Inc. | 1.90M | $68.0M | 6.70% | +178.5K | 2026-06-30 |
| Nantahala Capital Management, LLC | 1.18M | $42.0M | 4.16% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 976.6K | $35.0M | 3.45% | -17.5K | 2026-06-30 |
| MORGAN STANLEY | 768.0K | $27.0M | 2.71% | +290.0K | 2026-06-30 |
| STATE STREET CORP | 701.8K | $25.0M | 2.48% | +171.6K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 652.3K | $23.0M | 2.31% | +74.6K | 2026-06-30 |
| OBERWEIS ASSET MANAGEMENT INC/ | 501.6K | $18.0M | 1.77% | +62.3K | 2026-06-30 |
| National Philanthropic Trust | 492.1K | $17.0M | 1.74% | -- | 2026-06-30 |